Evolus Q1 2024 Adj EPS $(0.08) Beats $(0.10) Estimate, Sales $59.333M Beat $57.321M Estimate
Portfolio Pulse from Benzinga Newsdesk
Evolus (NASDAQ:EOLS) reported Q1 2024 earnings with an adjusted EPS of $(0.08), surpassing the $(0.10) estimate, and sales of $59.333M, exceeding the $57.321M forecast. This represents a significant improvement over the previous year, with a 46.67% decrease in losses per share and a 42.21% increase in sales.
May 07, 2024 | 8:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evolus reported a narrower Q1 2024 loss of $(0.08) per share, beating estimates, and sales of $59.333M, also above expectations. Year-over-year, losses decreased by 46.67% and sales increased by 42.21%.
Evolus's Q1 2024 financial results exceeded analyst expectations in both earnings per share and sales, indicating a strong financial performance and significant improvement over the previous year. This positive earnings report is likely to instill investor confidence and could lead to a short-term uptick in EOLS's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100